Improving anticancer efficacy of (–)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells

References

• Markovic SN Erickson LA Rao RD Melanoma Study Group of the Mayo Clinic Cancer Center Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis Mayo Clin Proc 2007 82 3 364 380 17352373
   PubMed Web of Science ®Google Scholar
• Guevara-Canales JO Gutiérrez-Morales MM Sacsaquispe-Contreras SJ Sánchez-Lihón J Morales-Vadillo R Malignant melanoma of the oral cavity. Review of the literature and experience in a Peruvian Population Med Oral Patol Oral Cir Bucal 2012 17 2 e206 e211 22143709
   PubMed Web of Science ®Google Scholar
• Pusceddu S Bajetta E Carcangiu ML Formisano B Ducceschi M Buzzoni R A literature overview of primary cervical malignant melanoma: an exceedingly rare cancer Crit Rev Oncol Hematol 2012 81 2 185 195 21515070
   PubMed Web of Science ®Google Scholar
• Vikey AK Vikey D Primary malignant melanoma, of head and neck: a comprehensive review of literature Oral Oncol 2012 48 5 399 403 22265336
   PubMed Web of Science ®Google Scholar
• Bhatia S Tykodi SS Thompson JA Treatment of metastatic melanoma: an overview Oncology (Williston Park) 2009 23 6 488 496 19544689
   PubMed Web of Science ®Google Scholar
• Sak K Chemotherapy and dietary phytochemical agents Chemother Res Pract 2012 2012 282570 23320169
   PubMedGoogle Scholar
• Alisi A Balsano C Enhancing the efficacy of hepatocellular carcinoma chemotherapeutics with natural anticancer agents Nutr Rev 2007 65 12 Pt 1 550 553 18236694
   PubMed Web of Science ®Google Scholar
• Kuo PL Lin CC Green tea constituent (–)-epigallocatechin-3-gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways J Biomed Sci 2003 10 2 219 227 12595758
   PubMed Web of Science ®Google Scholar
• Mukhtar H Agarwal R Skin cancer chemoprevention J Investig Dermatol Symp Proc 1996 1 2 209 214
   Google Scholar
• Singh BN Shankar S Srivastava RK Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications Biochem Pharmacol 2011 82 12 1807 1821 21827739
   PubMed Web of Science ®Google Scholar
• Kale A Gawande S Kotwal S Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract Phytother Res 2010 24 Suppl 1 S48 S55 19585479
   PubMed Web of Science ®Google Scholar
• Landis-Piwowar KR Huo C Chen D A novel prodrug of the green tea polyphenol (–)-epigallocatechin-3-gallate as a potential anticancer agent Cancer Res 2007 67 9 4303 4310 17483343
   PubMed Web of Science ®Google Scholar
• Dube A Nicolazzo JA Larson I Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (–)-epigallocatechin gallate Eur J Pharm Sci 2010 41 2 219 225 20600878
   PubMed Web of Science ®Google Scholar
• Xia Y Li W Cobley CM Gold nanocages: from synthesis to theranostic applications Acc Chem Res 2011 44 10 914 924 21528889
   PubMed Web of Science ®Google Scholar
• Hsieh DS Wang H Tan SW The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles Biomaterials 2011 32 30 7633 7640 21782236
   PubMed Web of Science ®Google Scholar
• Dreaden EC Alkilany AM Huang X Murphy CJ El-Sayed MA The golden age: gold nanoparticles for biomedicine Chem Soc Rev 2012 41 7 2740 2779 22109657
   PubMed Web of Science ®Google Scholar
• Schroeder A Heller DA Winslow MM Treating metastatic cancer with nanotechnology Nat Rev Cancer 2011 12 1 39 50 22193407
   PubMed Web of Science ®Google Scholar
• Love SA Maurer-Jones MA Thompson JW Lin YS Haynes CL Assessing nanoparticle toxicity Annu Rev Anal Chem (Palo Alto Calif) 2012 5 181 205 22524221
   PubMed Web of Science ®Google Scholar
• Maurer-Jones MA Bantz KC Love SA Marquis BJ Haynes CL Toxicity of therapeutic nanoparticles Nanomedicine (Lond) 2009 4 2 219 241 19193187
   PubMed Web of Science ®Google Scholar
• Mayer A Vadon M Rinner B Novak A Wintersteiger R Fröhlich E The role of nanoparticle size in hemocompatibility Toxicology 2009 258 2–3 139 147 19428933
   PubMed Web of Science ®Google Scholar
• Love SA Thompson JW Haynes CL Development of screening assays for nanoparticle toxicity assessment in human blood: preliminary studies with charged Au nanoparticles Nanomedicine (Lond) 2012 7 9 1355 1364 22583573
   PubMed Web of Science ®Google Scholar
• Hsieh DS Lu HC Chen CC Wu CJ Yeh MK The preparation and characterization of gold-conjugated polyphenol nanoparticles as a novel delivery system Int J Nanomedicine 2012 7 1623 1633 22615529
   PubMed Web of Science ®Google Scholar
• Bhumkar DR Joshi HM Sastry M Pokharkar VB Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin Pharm Res 2007 24 8 1415 1426 17380266
   PubMed Web of Science ®Google Scholar
• Kagan VE Bayir H Shvedova AA Nanomedicine and nanotoxicology: two sides of the same coin Nanomedicine 2005 1 4 313 316 17292104
   PubMed Web of Science ®Google Scholar
• Xu C Tung GA Sun S Size and Concentration Effect of Gold Nanoparticles on X-ray Attenuation As Measured on Computed Tomography Chemistry of Materials 2008 20 13 4167 4169 19079760
   PubMed Web of Science ®Google Scholar
• Cho EC Au L Zhang Q Xia Y The Effects of Size, Shape, and Surface Functional Group of Gold Nanostructures on Their Adsorption and Internalization by Cells Small 2010 6 4 517 522 20029850
   PubMed Web of Science ®Google Scholar
• Bonkovsky HL Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis) Ann Int Med 2006 144 1 68 71 16389263
   PubMed Web of Science ®Google Scholar
• Mazzanti G Menniti-Ippolito F Moro PA Hepatotoxicity from green tea: a review of the literature and two unpublished cases Eur J Clin Pharmacol 2009 65 4 331 341 19198822
   PubMed Web of Science ®Google Scholar
• Galati G Lin A Sultan AM O’Brien PJ Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins Free Radic Biol Med 2006 40 4 570 580 16458187
   PubMed Web of Science ®Google Scholar
• Lee JH Kishikawa M Kumazoe M Yamada K Tachibana H Vitamin A enhances antitumor effect of a green tea polyphenol on melanoma by upregulating the polyphenol sensing molecule 67-kDa laminin receptor PloS One 2010 5 6 e11051 20548792
   PubMed Web of Science ®Google Scholar
• Nihal M Roelke CT Wood GS Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (–)-epigallocatechin-3-gallate (EGCG) Pharm Res 2010 27 6 1103 1114 20232120
   PubMed Web of Science ®Google Scholar
• Suganuma M Saha A Fujiki H New cancer treatment strategy using combination of green tea catechins and anticancer drugs Cancer Sci 2011 102 2 317 323 21199169
   PubMed Web of Science ®Google Scholar
• Yang CS Wang X Lu G Picinich SC Cancer prevention by tea: animal studies, molecular mechanisms and human relevance Nat Rev Cancer 2009 9 6 429 439 19472429
   PubMed Web of Science ®Google Scholar
• Shankar S Ganapathy S Srivastava RK Green tea polyphenols: biology and therapeutic implications in cancer Front Biosci 2007 12 4881 4899 17569617
   PubMed Web of Science ®Google Scholar
• Galluzzi L Vitale I Abrams JM Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 Cell Death Differ 2012 19 1 107 120 21760595
   PubMed Web of Science ®Google Scholar
• Kroemer G Galluzzi L Vandenabeele P Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 Cell Death Differ 2009 16 1 3 11 18846107
   PubMed Web of Science ®Google Scholar
• Kerr JF Wyllie AH Currie AR Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics British Journal of Cancer 1972 26 4 239 257 4561027
   PubMed Web of Science ®Google Scholar
• Sharangi AB Medicinal and therapeutic potentialities of tea (Camellia sinensis L.) – a review Food Res Int 2009 42 5–6 529 535
   Web of Science ®Google Scholar
• Bug M Dobbelstein M Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms Oncogene 2011 30 33 3612 3624 21441950
   PubMed Web of Science ®Google Scholar
• Sonnenschein C Soto AM The death of the cancer cell. Cancer research July 1 2011 71 13 4334 4337
   Google Scholar
• Yang J Yu H Sun S Mechanism of free Zn(2+) enhancing inhibitory effects of EGCG on the growth of PC-3 cells: interactions with mitochondria Biol Trace Elem Res 2009 131 3 298 310 19326061
   PubMed Web of Science ®Google Scholar
• Yu HN Shen SR Yin JJ Effects of interactions of EGCG and Cd2+ on the growth of PC-3 cells and their mechanisms Food Chem Toxicol 2007 45 2 244 249 17046135
   PubMed Web of Science ®Google Scholar
• Shukla R Chanda N Zambre A Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer Proc Natl Acad Sci U S A 2012 109 31 12426 12431 22802668
   PubMed Web of Science ®Google Scholar
• Walsh SM Fisher SG Sage RA Survival of patients with primary pedal melanoma J Foot Ankle Surg 2003 42 4 193 198 12907929
   PubMedGoogle Scholar
• Xie H Goins B Bao A Wang ZJ Phillips WT Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells Int J Nanomedicine 2012 7 2227 2238 22619558
   PubMed Web of Science ®Google Scholar
• Yiannakopoulou ECh Targeting oxidative stress response by green tea polyphenols: clinical implications Free Radic Res 2013 47 9 667 671 23805775
   PubMed Web of Science ®Google Scholar
• Kanadzu M Lu Y Morimoto K Dual function of (–)-epigallocatechin gallate (EGCG) in healthy human lymphocytes Cancer Lett 2006 241 2 250 255 16303244
   PubMed Web of Science ®Google Scholar
• Lundqvist M Stigler J Elia G Lynch I Cedervall T Dawson KA Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts Proc Natl Acad Sci U S A 2008 105 38 14265 14270 18809927
   PubMed Web of Science ®Google Scholar
• Monopoli MP Walczyk D Campbell A Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles J Am Chem Soc 2011 133 8 2525 2534 21288025
   PubMed Web of Science ®Google Scholar
• Maiorano G Sabella S Sorce B Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response ACS Nano 2010 4 12 7481 7491 21082814
   PubMed Web of Science ®Google Scholar
• Lacerda SH Park JJ Meuse C Interaction of gold nanoparticles with common human blood proteins ACS Nano 2010 4 1 365 379 20020753
   PubMed Web of Science ®Google Scholar
• Duan J Yu Y Li Y Yu Y Li Y Zhou X Toxic effect of silica nanoparticles on endothelial cells through DNA damage response via Chk1-dependent G2/M checkpoint PloS one 2013 8 4 e62087 23620807
   PubMed Web of Science ®Google Scholar
• Bombelli FB Webster CA Moncrieff M Sherwood V The scope of nanoparticle therapies for future metastatic melanoma treatment Lancet Oncol 2014 15 1 e22 e32 24384491
   PubMed Web of Science ®Google Scholar
• Chen CC Wu CJ Yeh MK Gold nanoparticle-based platforms as cancer-targeted molecules delivery systems Int J Nanotechnol 2013 10 10/11 840 849
   Web of Science ®Google Scholar
• Mukherjee P Bhattacharya R Wang P Antiangiogenic properties of gold nanoparticles Clin Cancer Res 2005 11 9 3530 3534 15867256
   PubMed Web of Science ®Google Scholar